Literature DB >> 32224003

Evaluation of the Medial Stabilized Knee Design Using Data From National Joint Registries and Current Literature.

Adrian J Cassar-Gheiti1, Paul S Jamieson1, Mehran Radi1, Jesse I Wolfstadt1, David J Backstein1.   

Abstract

BACKGROUND: Various designs of total knee arthroplasty (TKA) have provided satisfactory outcomes for the treatment of knee osteoarthritis for many years. The aim of the study is to evaluate the success and failure rate of the medial stabilized (MS) TKA design through national joint registries and the current literature.
MATERIALS AND METHODS: A comprehensive literature review using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses was carried out through PubMed and MEDLINE database. The international registries analyzed included the National Joint Registry, the Australian Orthopedic Association National Joint Replacement Registry, the Dutch Arthroplasty Register, the New Zealand Orthopedic Association Joint Registry, and the Michigan Arthroplasty Registry Collaborative Quality Initiative. We are reporting descriptive data which include means and percentages of survival rates and revision rates and number of years after the primary procedure. The revision rates and the cumulative revision rates are reported separately for each MS implant.
RESULTS: Our detailed review identified 5 of 12 registries and 25 of 550 studies reporting on the survivorship of an MS TKA design. There were a total of 3684 procedures between the 25 studies, with an average survivorship free of aseptic loosening of 99% at 6.9 years. There are 26,693 (2.5%) MS TKAs in the current National Joint Registry with a mean cumulative revision rate of 2.63% at 5 years, 3.35% at 10 years, and 4.6% at 15 years. The Australian Orthopedic Association National Joint Replacement Registry provides survivorship data on 19,249 (2.9%) MS TKAs, with a mean cumulative revision rate of 3.34% at 5 years, 7.4% at 10 years, and 8.1% at 15 years. The Dutch Arthroplasty Register contains survivorship data on 1490 MS designs and a mean revision rate of these implants is 0.8% at 1 year, 5.95% at 5 years, and 9.8% at 10 years. The Evolution MP is the only implant reported in the Michigan Arthroplasty Registry Collaborative Quality Initiative and has a revision rate of 2.28% at 3 years.
CONCLUSION: The MS TKA design has comparable results to traditional TKA designs across several joint registries and 25 studies in the literature.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  medial ball and socket; medial congruent; medial pivot; medial rotating knee; medial stabilized; total knee arthroplasty

Mesh:

Year:  2020        PMID: 32224003     DOI: 10.1016/j.arth.2020.02.026

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  4 in total

1.  Comparative Analysis of Contemporary Fixed Tibial Inserts: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials.

Authors:  John Krumme; Roma Kankaria; Madana Vallem; John Cyrus; Peter Sculco; Gregory Golladay; Niraj Kalore
Journal:  Orthop Rev (Pavia)       Date:  2022-06-27

Review 2.  Mid-term survivorship and clinical outcomes of the medial stabilized systems in primary total knee arthroplasty: A systematic review.

Authors:  Giorgio Cacciola; Fabio Mancino; Federico De Meo; Vincenzo Di Matteo; Peter K Sculco; Pietro Cavaliere; Giulio Maccauro; Ivan De Martino
Journal:  J Orthop       Date:  2021-02-22

Review 3.  Medial stabilised total knee arthroplasty achieves comparable clinical outcomes when compared to other TKA designs: a systematic review and meta-analysis of the current literature.

Authors:  Sohail Nisar; Kashif Ahmad; Jeya Palan; Hemant Pandit; Bernard van Duren
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-11-27       Impact factor: 4.114

4.  Similar migration for medial congruent and cruciate-retaining tibial components in an anatomic TKA system: a randomized controlled trial of 60 patients followed with RSA for 2 years.

Authors:  Albin Christensson; Magnus Tveit; Uldis Kesteris; Gunnar Flivik
Journal:  Acta Orthop       Date:  2022-01-03       Impact factor: 3.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.